Trial NCT00363610

View at ClinicalTrials.gov 
Org. Study IDs: EZ-002-001

Last trial update was posted on 2008-05-20

MeSH Interventions

Pegaspargase

MeSH Conditions

Lymphoma

Other Conditions

Tumors

Stopping Reasons

No recommended Phase II dose was determined.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID